← Back to Search

12-hour IO-therapy Glasses for Lazy Eye

N/A
Waitlist Available
Led By Jingyun Wang, PhD
Research Sponsored by Salus University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 3 to < 8 years
Amblyopia associated with strabismus, anisometropia, or both
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12± 1 weeks after treatment
Awards & highlights

Study Summary

This study is designed to evaluate the effectiveness of a novel amblyopia treatment - Intermittent occlusion therapy (IO-therapy) glasses (AmblyzTM) in treating severe amblyopia. Children ages 3 to 8 years with severe amblyopia (visual acuity of 20/100 to 20/400 in the amblyopic eye) will be enrolled and randomized into two groups: 1) standard 6-hour patching group or 2) 12-hour IO-therapy glasses group. The study also observe the effectiveness of IO-therapy glasses on two types of difficult amblyopia: deprivation amblyopia associated with congenital or developmental cataract, and myopic anisometropic amblyopia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12± 1 weeks after treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12± 1 weeks after treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual Acuity Improvement

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 12-hour IO-therapy GlassesExperimental Treatment1 Intervention
wear IO-therapy glasses for 12-hour
Group II: 6-hour patchingActive Control1 Intervention
wear the eye patch for 6-hour

Find a Location

Who is running the clinical trial?

Salus UniversityLead Sponsor
14 Previous Clinical Trials
939 Total Patients Enrolled
Indiana UniversityOTHER
977 Previous Clinical Trials
983,295 Total Patients Enrolled
Jingyun Wang, PhDPrincipal InvestigatorSalus University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Maine
What site did they apply to?
Salus University
What portion of applicants met pre-screening criteria?
Did not meet criteria
~2 spots leftby Mar 2025